10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Hyperthyroid heart disease

      review-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The heart is an organ sensitive to the action of thyroid hormone, and measurable changes in cardiac performance are detected with small variations in thyroid hormone serum concentrations. Most patients with hyperthyroidism experience cardiovascular manifestations, and the most serious complications of hyperthyroidism occur as a result of cardiac involvement. Recent studies provide important insights into the molecular pathways that mediate the action of thyroid hormone on the heart and allow a better understanding of the mechanisms that underlie the hemodynamic and clinical manifestations of hyperthyroidism. Several cardiovascular conditions and drugs can interfere with thyroid hormone levels and may pose a difficulty in interpretation of laboratory data in patients with suspected thyroid heart disease. The focus of this report is a review of the current knowledge of thyroid hormone action on the heart and the clinical and hemodynamic laboratory findings as well as therapeutic management of patients with hyperthyroid heart disease.

          Related collections

          Author and article information

          Journal
          Clin Cardiol
          Clin Cardiol
          10.1002/(ISSN)1932-8737
          CLC
          Clinical Cardiology
          Wiley Periodicals, Inc. (New York )
          0160-9289
          1932-8737
          03 February 2009
          June 2000
          : 23
          : 6 ( doiID: 10.1002/clc.v23:6 )
          : 402-408
          Affiliations
          [ 1 ]Division of Cardiovascular Medicine, Stanford University, Stanford, and Palo Alto Veterans Affairs Medical Center, Palo Alto, California, USA
          [ 2 ]Division of Cardiology, Washington Hospital Center, Washington, D.C., USA
          [ 3 ]Division of Endocrinology, Washington Hospital Center, Washington, D.C., USA
          Author notes
          [*] [* ]Division of Cardiovascular Medicine Stanford University 300 Pasteur Drive, CVRC Stanford CA 94305‐5406‐
          Article
          PMC6654928 PMC6654928 6654928 CLC4960230605
          10.1002/clc.4960230605
          6654928
          10875028
          ce6d3720-9a09-43aa-9372-b591037491aa
          Copyright © 2000 Wiley Periodicals, Inc.
          History
          : 26 July 1999
          : 29 September 1999
          Page count
          Figures: 2, Tables: 3, References: 59, Pages: 7
          Categories
          Review
          Reviews
          Custom metadata
          2.0
          June 2000
          Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.2.1 mode:remove_FC converted:09.05.2019

          hyperthyroidism,atrial fibrillation,heart failure,thyroid hormone

          Comments

          Comment on this article